Sun Pharma Q4 Result | Firm posts surprise loss of Rs 2,227 crore - Moneycontrol

The company also informed the stock exchanges that it has reappointed Dilip Shanghvi as its managing director for a five-year period.

Sun Pharmaceuticals Industries Ltd on May 30 reported a surprise loss for the quarter ended March 2022 (Q4FY22), hit by one-time charges. The Mumbai-based company posted a net loss of Rs 2,227.38 cr… [+3116 chars]

full article...